Download full-text PDF |
Source |
---|
Maturitas
November 2024
Hormone Hamburg, Hamburg, Germany. Electronic address:
Objective: To report patient-reported quality-of-life (QOL) outcomes in the DAYLIGHT study.
Study Design: DAYLIGHT was a phase 3b, randomized, double-blind, 24-week, placebo-controlled study. Participants were women aged ≥40 to ≤65 years with moderate to severe vasomotor symptoms (VMS) considered unsuitable for hormone therapy (HT) (contraindications, caution, stoppers, or averse) randomized 1:1 to placebo or fezolinetant 45 mg once daily.
Microbiome
January 2025
Instituto de Investigación de La Viña y El Vino, Escuela de Ingeniería Agraria, Universidad de León, Avenida de Portugal, 41, León, 24009, Spain.
Dis Colon Rectum
December 2024
Department of Colorectal Surgery, Cleveland Clinic, Ohio, United States.
Background: Deloyers technique addresses challenges in restoring bowel continuity following extended left hemicolectomies. Despite being first described in 1958, the technique remains underutilized, with limited data on long-term outcomes.
Objective: To evaluate the indications, surgical and functional outcomes of Deloyers technique and review existing literature.
Int J Oral Maxillofac Surg
January 2025
Christian Albrecht's University, Department of Oral and Maxillofacial Surgery, Arnold-Heller-Straße 3, Haus B, UKSH, 24105 Kiel, Germany.
The reported complications after arthrocentesis of the temporomandibular joint are rare, which makes it to an outpatient and safe oral and maxillofacial surgical procedure. A penetration into the middle cranial fossa is an extremely rare but serious complication for the conventional needle arthrocentesis. The simple technical modification described herein could help to easily retain the puncture depth via an endodontic silicone stopper to avoid this rare complication.
View Article and Find Full Text PDFClin Pract Cases Emerg Med
November 2024
Loma Linda University Medical Center, Department of Emergency Medicine, Loma Linda, California.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!